Bonita R. Bryant

Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer

Kevin C. Conlon, Enrico Lugli, Hugh C. Welles et al. · Journal of Clinical Oncology · 2014 · 702 citations · Full text

Life Sciences, Immunology, Oncology +17

Pleomorphic Lobular Carcinoma: Morphology, Immunohistochemistry, and Molecular Analysis

Lavinia P. Middleton, Diana Palacios, Bonita R. Bryant et al. · The American Journal of Surgical Pathology · 2000 · 205 citations

Medicine, Cancer Biology, Oncology +17

Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques

Thomas A. Waldmann, Enrico Lugli, Mario Roederer et al. · Blood · 2011 · 194 citations · Full text

Life Sciences, Immunology, Pharmacokinetics +12

IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion

Kevin C. Conlon, E. Lake Potter, Stefania Pittaluga et al. · Clinical Cancer Research · 2019 · 133 citations

Pharmacy, Oncology, Pharmacology +14

Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma

Masao Nakagawa, Arthur L. Shaffer, Michele Ceribelli et al. · Cancer Cell · 2018 · 123 citations · Full text

Medicine, Molecular Genetics, Oncology +11